AZN: AstraZeneca PLC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AZN: AstraZeneca PLC

AZN 82.25

-0.4%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: EdR who wrote (22)	8/30/2002 1:47:00 PM
From: keokalani'nui	of 35

Press Release Source: IVAX Corporation IVAX Receives Tentative Approval For Tamoxifen Friday August 30, 1:07 pm ET MIAMI--(BUSINESS WIRE)--Aug. 30, 2002--IVAX Corporation (AMEX:IVX - News; LSE:IVX.L) announced today it has received tentative approval from the FDA of its Abbreviated New Drug Application (ANDA) for tamoxifen citrate tablets in 10 mg and 20 mg strengths. Upon final approval, this product will be sold through the company's wholly owned subsidiary, IVAX Pharmaceuticals, Inc. Tamoxifen citrate is used for the treatment of breast cancer. It is the generic equivalent of Nolvadex® Tablets marketed by AstraZeneca. IVAX now currently has 34 ANDAs approvals and two tentative approvals pending at the FDA. The company is continuing its aggressive filing schedule for new ANDA submissions.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next